3 ms·
> Good clinical outcome and virological cure were obtained in 973 patients within 10 days (91.7%). I think that's pretty typical in untreated patients. Average
by arcticbull 7y ago
> Good clinical outcome and virological cure were obtained in 973 patients within 10 days (91.7%).
I think that's pretty typical in untreated patients. Average recovery period is about two weeks. [1]
> Death rate with HCQ+AZ is 0.75%
The death rate of COVID-19 in the general population is less than 1% (0.25%-1% depending on the study). Even New York, the worst city (by case count, and fatalities) in the worst country in the world is ~0.7%. All this study shows is that HCQ+AZ doesn't kill people faster than not taking HCQ+AZ.
> AND, death rate in france for closed cases is around - 15-25%.
Not worth re-hashing CFR vs. IFR (and the associated adverse selection risk) but you won't get anything approximating your risk without referencing serological studies. I can't stress how this number is not representative, and treating with HCQ+AZ does not by any means get the number from 15-25% down to 0.7%
[1] https://www.bbc.com/news/health-52301633 https://www.bbc.com/news/health-52301633
- klmadfejno 7y ago> Even New York, the worst city in the worst country in the world Pretty sure this is inaccurate, except perhaps by total number of deaths...
- arcticbull 7y agoThat is what I meant, yeah. Edited for clarity.